MedPath

FLUORoscopy-Only based interventional closure of the left atrial appendage using the WATCHMAN FLX in patients with atrial fibrillation and contraindication against oral anticoagulation – feasibility and safety

Recruiting
Conditions
Atrial fibrillation and atrial flutter, unspecified
I48.9
Registration Number
DRKS00023464
Lead Sponsor
Katholisches Krankenhaus St. Johan Nepomuk Erfurt
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

• age >18 Jahre
• atrial fibrillation (paroxysmal, persistent, or permanent) with a scheduled interventional closure of the left atrial appendage
• signed informed consent
• exclusion of intracardiac thrombi by cardiac CT within 72 hours before the LAAC
• no long-term interruption of oral anticoagulation before the LAAC (last dose of NOAC or low molecular weight heparin within 36 h before LAAC)

Exclusion Criteria

•history of open heart surgery
•unsuitable anatomy for LAAC due to cardiac CT
•history of ASD/ PFO closure
•contraindication regarding TEE
•lack of informed consent
•impossibility to perform follow-up TEE after 3 months

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the study should determine how often the LAAC procedure has to be changed due to information from the TEE; the efficacy endpoint is defined as the frequency of interruption of the LAAC by TEE
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath